Scientists at the University of Cambridge on Tuesday began a clinical trial of a needle-free air-powered vaccine, which is expected to help combat future variants of COVID-19. Developed by Professor Jonathan Heeney at the University of Cambridge and spin-out company DIOSynVax,
http://dlvr.it/SFTC5x

